These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31625189)

  • 21. Hepatocellular carcinoma with or without cirrhosis: a comparison of CT and angiographic presentations in the United States and Japan.
    Yamashita Y; Takahashi M; Baba Y; Kanazawa S; Charnsangavej C; Yang D; Wallace S
    Abdom Imaging; 1993; 18(2):168-75. PubMed ID: 8382545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do occupational exposures to vinyl chloride cause hepatocellular carcinoma and cirrhosis?
    Lotti M
    Liver Int; 2017 May; 37(5):630-633. PubMed ID: 28063180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis.
    del Olmo JA; Serra MA; Rodríguez F; Escudero A; Gilabert S; Rodrigo JM
    J Cancer Res Clin Oncol; 1998; 124(10):560-4. PubMed ID: 9829860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
    Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
    Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective analysis of risk factors for hepatocellular carcinoma on patients with cirrhosis.
    Di Costanzo GG
    Hepatology; 2003 Oct; 38(4):1061; author reply 1061. PubMed ID: 14512897
    [No Abstract]   [Full Text] [Related]  

  • 26. Persistence of hepatocellular carcinoma risk in hepatitis C patients with a response to IFN and cirrhosis regression.
    D'Ambrosio R; Aghemo A; Rumi MG; Degasperi E; Sangiovanni A; Maggioni M; Fraquelli M; Perbellini R; Rosenberg W; Bedossa P; Colombo M; Lampertico P
    Liver Int; 2018 Aug; 38(8):1459-1467. PubMed ID: 29377616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for hepatocellular carcinoma in cirrhosis.
    Bolondi L
    J Hepatol; 2003 Dec; 39(6):1076-84. PubMed ID: 14642630
    [No Abstract]   [Full Text] [Related]  

  • 28. Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosis.
    Granito A; Bolondi L
    Lancet Oncol; 2017 Feb; 18(2):e101-e112. PubMed ID: 28214411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Surgical resection of hepatocellular carcinoma. Retrospective study of 42 cases].
    Huguet C; Nordlinger B; Vacher B; Parc R; Hakami F; Loygue J
    Gastroenterol Clin Biol; 1985 Mar; 9(3):244-9. PubMed ID: 2989066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Is follow up of hepatocellular carcinoma in patients with liver cirrhosis justified?].
    Prat F
    Gastroenterol Clin Biol; 1992; 16(11):910. PubMed ID: 1282892
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatitis E virus as an agent of hepatocellular carcinoma.
    Colson P; Borentain P; Gérolami R
    Int J Infect Dis; 2019 Mar; 80():62-63. PubMed ID: 30634042
    [No Abstract]   [Full Text] [Related]  

  • 32. [Liver transplantation for hepatocellular carcinoma. Mid-term results].
    Gugenheim J; Crafa F; Fabiani P; Saint-Paul MC; Goubaux B; Ouzan D; Mouiel J
    Presse Med; 1992 Nov; 21(39):1846-8. PubMed ID: 1337383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES.
    Li DK; Yan P; Abou-Samra AB; Chung RT; Butt AA
    Aliment Pharmacol Ther; 2018 Jan; 47(2):246-258. PubMed ID: 29105111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural History of Hepatitis C.
    Lingala S; Ghany MG
    Gastroenterol Clin North Am; 2015 Dec; 44(4):717-34. PubMed ID: 26600216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study.
    Simonetti RG; Cammà C; Fiorello F; Cottone M; Rapicetta M; Marino L; Fiorentino G; Craxì A; Ciccaglione A; Giuseppetti R
    Ann Intern Med; 1992 Jan; 116(2):97-102. PubMed ID: 1309286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosis.
    Blumberg RS; Chopra S; Ibrahim R; Crawford J; Farraye FA; Zeldis JB; Berman MD
    Gastroenterology; 1988 Nov; 95(5):1399-402. PubMed ID: 2844622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular Carcinoma Screening Associated with Early Tumor Detection and Improved Survival Among Patients with Cirrhosis in the US.
    Singal AG; Mittal S; Yerokun OA; Ahn C; Marrero JA; Yopp AC; Parikh ND; Scaglione SJ
    Am J Med; 2017 Sep; 130(9):1099-1106.e1. PubMed ID: 28213044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Healthcare Costs Related to Treatment of Hepatocellular Carcinoma Among Veterans With Cirrhosis in the United States.
    Kaplan DE; Chapko MK; Mehta R; Dai F; Skanderson M; Aytaman A; Baytarian M; D'Addeo K; Fox R; Hunt K; Pocha C; Valderrama A; Taddei TH;
    Clin Gastroenterol Hepatol; 2018 Jan; 16(1):106-114.e5. PubMed ID: 28756056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver cell dysplasia and risk of hepatocellular carcinoma in cirrhosis: a preliminary report.
    Borzio M; Bruno S; Roncalli M; Mels GC; Ramella G; Borzio F; Leandro G; Podda M
    BMJ; 1991 Jun; 302(6788):1312. PubMed ID: 1647827
    [No Abstract]   [Full Text] [Related]  

  • 40. [High risk group for evolution of hepatocellular carcinoma from HCV related liver cirrhosis].
    Hayashi S
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):736-9. PubMed ID: 7563866
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.